light therapy Guide

Fda Approved Light Therapy Section


 


Social bookmarking
You like it? Share it!
socialize it

Newsletter

Subscribe to our newsletter AND receive our exclusive Special Report on light-therapy
Email:
First Name:


Main Fda Approved Light Therapy sponsors


 

 

Welcome to light therapy Guide

 

Fda Approved Light Therapy Article

Thumbnail example. For a permanent link to this article, or to bookmark it for further reading, click here.

Using Light Therapy for Depression

from:

Depression is one of the few disorders that can be treated successfully, and it responds well to it. But to find out which type of treatment works best is difficult, especially one that is new to the market such as light therapy for depression. But there are many medical conditions similar to depression, and medications can cause the symptoms of depression--fatigue, loss of pleasure, or sadness. And for a fact depression will not leave until the actual problem is not only identified but treated correctly.

Conventional methods for treating depression include psychotherapy, electroconvulsive or ECT therapy, and antidepressant drugs. The medical field recognizes that treatments for depression can vary, depending on its severity and its cause. Both holistic practitioners and traditional medical physicians agree that for extremely serious depressions, light therapy for depression should be considered as a complementary treatment as compared to the conventional ones.

These complementary conditions considered acceptable for light therapy for depression would be seasonal depression or seasonal affective disorders, not major or chronic depressions such as manic depression or manor depressive disorders. But there are several other conditions, including the light therapy for depression of SAD, that accept light therapy as an excellent treatment--early morning insomnia, productivity enhancement, night-owl insomnia, jet lag, late-shift drowsiness, bulimia, lupus, nonseasonal depression, or even prolonged menstrual cycles.

A lot of the early research on light therapy for depression has been inadequately funded, which has led to its lack of research at the very beginning. Also the studies had lots of flaws in its design problems, which caused them to be weak in their quality.

But research in Canada has completed one of the most recent studies that says light therapy for depression is just as effective of a treatment as medications, and is considered to be the safest treatment for bipolar depression. And not only is it effective, it is cheaper than traditional medication and treatments, in addition to being much safer with fewer side effects. Almost all of antidepressant treatments, except lithium, have the ability to make the condition of bipolar disorder much worse than without them, forcing an increase of subtle "manic side" symptoms.

When applying light therapy for depression treatments for winter depression or season affective disorder, light therapy originally started out with early morning treatments. But recent results have demonstrated how light therapy treats depression is still unknown, and is very much unestablished in its results. Recent studies have shown us that research in light therapy may occur in the evenings or other times with just as good of results.

 

Fda Approved Light Therapy News

Therapy Lasers: Too Good to be True? - VetPracticeNews.com


Therapy Lasers: Too Good to be True?
VetPracticeNews.com
After years of inferior products and exaggerated claims, we must be specific and accurate with our statements. So this is not a discussion of “lighttherapy but “laser” therapy. More specifically, we are talking mainly about high power laser therapy.

and more »

Read more...


In rare slap, FDA review rips up Pfizer's case for tafamidis - FierceBiotech


In rare slap, FDA review rips up Pfizer's case for tafamidis
FierceBiotech
Pfizer, though, plans to put its case on the drug in the best light possible. "There is currently no FDA-approved treatment designed specifically to treat TTR-FAP," Pfizer noted in a statement to FierceBiotech this morning. "If approved by the FDA, ...
FDA staff not impressed with Pfizer rare disease drug tafamidisPharma Times

all 39 news articles »

Read more...


MedX Health Corp. Enters India - One of the World's Largest and Fastest ... - Stockhouse


MedX Health Corp. Enters India - One of the World's Largest and Fastest ...
Stockhouse
MDX) with worldwide revenues in drug free, non-invasive low level laser light therapy and light imaging systems, announced that their distribution partner in India, HealthX Lasers (www.healthxlasers.com), is working with hospitals, physicians, clinics, ...

and more »

Read more...


FDA staff backs J&J's Xarelto for heart condition - FierceBiotech


FDA staff backs J&J's Xarelto for heart condition
FierceBiotech
As Johnson & Johnson ($JNJ) builds the blockbuster pedigree of Xarelto, an FDA reviewer has given the thumbs-up to the new clot-busting drug as a treatment for the heart problem known as acute coronary syndrome. The staffers' recommendation of approval ...

and more »

Read more...


Viral Genetics' P-IND Clears FDA To Commence Clinical Trials in Humans - MarketWatch (press release)


Viral Genetics' P-IND Clears FDA To Commence Clinical Trials in Humans
MarketWatch (press release)
The P-IND -- part of a larger, coordinated research effort -- was submitted by the first test site at the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio, which includes patient enrollment at ...

and more »

Read more...